These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 29386504)
1. Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control. Schmid M; Ernst P; Honegger A; Suomalainen M; Zimmermann M; Braun L; Stauffer S; Thom C; Dreier B; Eibauer M; Kipar A; Vogel V; Greber UF; Medalia O; Plückthun A Nat Commun; 2018 Jan; 9(1):450. PubMed ID: 29386504 [TBL] [Abstract][Full Text] [Related]
2. Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX. Poulin KL; Lanthier RM; Smith AC; Christou C; Risco Quiroz M; Powell KL; O'Meara RW; Kothary R; Lorimer IA; Parks RJ J Virol; 2010 Oct; 84(19):10074-86. PubMed ID: 20631131 [TBL] [Abstract][Full Text] [Related]
3. Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses. Bradshaw AC; Coughlan L; Miller AM; Alba R; van Rooijen N; Nicklin SA; Baker AH J Control Release; 2012 Dec; 164(3):394-402. PubMed ID: 22626939 [TBL] [Abstract][Full Text] [Related]
4. Human full-length coagulation factor X and a GLA domain-derived 40-mer polypeptide bind to different regions of the adenovirus serotype 5 hexon capsomer. Sumarheni S; Hong SS; Josserand V; Coll JL; Boulanger P; Schoehn G; Fender P Hum Gene Ther; 2014 Apr; 25(4):339-49. PubMed ID: 24512117 [TBL] [Abstract][Full Text] [Related]
5. Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity. Krutzke L; Prill JM; Engler T; Schmidt CQ; Xu Z; Byrnes AP; Simmet T; Kreppel F J Control Release; 2016 Aug; 235():379-392. PubMed ID: 27302248 [TBL] [Abstract][Full Text] [Related]
6. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. Croyle MA; Chirmule N; Zhang Y; Wilson JM Hum Gene Ther; 2002 Oct; 13(15):1887-900. PubMed ID: 12396620 [TBL] [Abstract][Full Text] [Related]
7. Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo. Prill JM; Subr V; Pasquarelli N; Engler T; Hoffmeister A; Kochanek S; Ulbrich K; Kreppel F PLoS One; 2014; 9(1):e82716. PubMed ID: 24475024 [TBL] [Abstract][Full Text] [Related]
8. Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies. Pacesa M; Hendrickx R; Bieri M; Flatt JW; Greber UF; Hemmi S Virol J; 2017 Aug; 14(1):158. PubMed ID: 28821267 [TBL] [Abstract][Full Text] [Related]
9. Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer. Belousova N; Mikheeva G; Gelovani J; Krasnykh V J Virol; 2008 Jan; 82(2):630-7. PubMed ID: 17989185 [TBL] [Abstract][Full Text] [Related]
11. Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector. Myhre S; Henning P; Granio O; Tylö AS; Nygren PA; Olofsson S; Boulanger P; Lindholm L; Hong SS Gene Ther; 2007 Feb; 14(4):376-81. PubMed ID: 17036056 [TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon. Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297 [TBL] [Abstract][Full Text] [Related]
13. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. Krasnykh V; Belousova N; Korokhov N; Mikheeva G; Curiel DT J Virol; 2001 May; 75(9):4176-83. PubMed ID: 11287567 [TBL] [Abstract][Full Text] [Related]
14. A strategy for adenovirus vector targeting with a secreted single chain antibody. Glasgow JN; Mikheeva G; Krasnykh V; Curiel DT PLoS One; 2009 Dec; 4(12):e8355. PubMed ID: 20027223 [TBL] [Abstract][Full Text] [Related]
15. Formulation and in vitro and in vivo evaluation of a cationic emulsion as a vehicle for improving adenoviral gene transfer. Kim SY; Lee SJ; Lim SJ Int J Pharm; 2014 Nov; 475(1-2):49-59. PubMed ID: 25138255 [TBL] [Abstract][Full Text] [Related]
20. In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor. Smith T; Idamakanti N; Kylefjord H; Rollence M; King L; Kaloss M; Kaleko M; Stevenson SC Mol Ther; 2002 Jun; 5(6):770-9. PubMed ID: 12027562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]